Evidence map›Paper›PMID 42691202›Full record

ArticleFunction (Oxford, England)2026

Evidence that myoglobin Po

Ryan M Broxterman, Bradley A Ruple, Peter D Wagner, Russell S Richardson

Abstract read
In one paragraph

Article in Function (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ryan M BroxtermanDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah, United States.ORCID 0000-0002-7388-2214
Bradley A RupleDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah, United States.
Peter D WagnerDepartment of Medicine, University of California, San Diego, California, United States.
Russell S RichardsonDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah, United States.

Funding

Tissue Imaging, Biochemistry and MorphologyP01HL091830 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WAGNER, PETER D · 2009 to 2013
$10.1M
Cardiovasomobility Research Training ProgramT32HL139451 · NHLBI · UNIVERSITY OF UTAH · PI SUPIANO, MARK A, WRAY, D. WALTER · 2018 to 2022
$1.4M
CSRD VA IK2 CX002114NHLBI NIH HHS P01 HL091830NHLBI NIH HHS T32 HL139451
6 · The paper itself

Abstract

Muscle mitochondrial partial pressure of oxygen ([Formula: see text]) is a key determinant of skeletal muscle oxygen consumption ([Formula: see text]), metabolism, gene regulation, and adaptation in health and disease. Yet [Formula: see text] remains difficult to measure directly in vivo in humans during exercise. Myoglobin-associated Po

Indexed as

ExerciseMitochondria, MuscleMuscle, SkeletalMyoglobinOxygenOxygen ConsumptionAdultHumansMaleYoung AdultMyoglobinOxygen1H-MRSmaximal oxygen uptakemitochondriaskeletal muscle

Identifiers

PMID42691202
PMCPMC13626265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.